Ozempic Cannot Be Ordered as Pills - It Is Only Available as a Subcutaneous Injection
Ozempic (semaglutide) is not available in pill form and must be prescribed as a once-weekly subcutaneous injection. The brand name "Ozempic" specifically refers to the injectable formulation only 1.
Available Formulations of Semaglutide
Injectable Ozempic (Subcutaneous)
- Pre-filled pen devices containing semaglutide solution (1.34 mg/mL) 1
- Administered once weekly via subcutaneous injection to abdomen, thigh, or upper arm 1
- Available in three pen types delivering different dose ranges 1
Oral Semaglutide (Different Brand)
If you're seeking an oral formulation, oral semaglutide exists as a separate product (brand name Rybelsus, not Ozempic):
- Daily tablet formulation at 3 mg, 7 mg, or 14 mg doses 2
- Must be taken at least 30 minutes before first food/fluid of the day with ≤120 mL plain water 2
- Has only ~1% bioavailability compared to 89% for subcutaneous 3
- Not interchangeable with injectable Ozempic - different dosing, different product
How to Prescribe Injectable Ozempic
Dosing Schedule
- Initiation: 0.25 mg once weekly for 4 weeks (not effective for glycemic control, only for tolerability) 1
- Maintenance: Increase to 0.5 mg once weekly after 4 weeks 1
- Optional escalation: May increase to 1 mg once weekly if additional glycemic control needed after ≥4 weeks on 0.5 mg 1
- Maximum dose: 1 mg once weekly 1
Administration Instructions for Patients
- Inject same day each week, any time of day, with or without meals 1
- Rotate injection sites (abdomen, thigh, upper arm) 1
- Day can be changed if ≥2 days (48 hours) between doses 1
- If dose missed: Give within 5 days; if >5 days passed, skip and resume regular schedule 1
Prescription Specifications
Write for pre-filled pen devices:
- Initiation pen: 2 mg/1.5 mL delivering 0.25 mg or 0.5 mg doses 1
- Maintenance pen: 2 mg/1.5 mL or 4 mg/3 mL delivering 1 mg doses 1
Clinical Indications
FDA-Approved Uses
- Glycemic control in type 2 diabetes as adjunct to diet/exercise 1
- Cardiovascular risk reduction (CV death, MI, stroke) in type 2 diabetes with established CVD 1, 4
Evidence-Based Applications
For type 2 diabetes with cardiovascular disease or kidney disease, GLP-1 receptor agonists like semaglutide are recommended as first-line therapy alongside or instead of metformin 2. The SUSTAIN-6 trial demonstrated 26% reduction in major adverse cardiovascular events (HR 0.74,95% CI 0.58-0.95) 4.
For obesity management, while injectable semaglutide 2.4 mg weekly (brand name Wegovy, not Ozempic) is FDA-approved, Ozempic at 1 mg weekly provides substantial weight loss (mean 14.9% at 68 weeks in STEP trials) 5, 6.
Critical Safety Considerations
Contraindications
- Personal or family history of medullary thyroid carcinoma 1
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) 1
- Known hypersensitivity to semaglutide 1
Black Box Warning
Risk of thyroid C-cell tumors observed in rodent studies; human relevance unknown 1. Counsel patients about neck mass, dysphagia, dyspnea, persistent hoarseness 1.
Common Adverse Effects
- Gastrointestinal: Nausea (most common), vomiting, diarrhea, constipation 7, 3
- Typically transient, mild-to-moderate, dose-dependent 3
- Mitigation strategy: Slow dose titration as outlined above 8
Serious Risks to Monitor
- Pancreatitis: Discontinue if suspected 1
- Acute kidney injury: Monitor when initiating/escalating in renal impairment 5
- Gallbladder disease: Cholelithiasis reported 8, 9
- Delayed gastric emptying: May affect absorption of oral medications requiring rapid onset 8
Renal Dosing
No dose adjustment required for any level of renal function 2. This distinguishes semaglutide from some other GLP-1 receptor agonists that require caution or are contraindicated in severe renal impairment 2.
Drug Interactions
- Do not combine with other GLP-1 receptor agonists or DPP-4 inhibitors 8
- Use caution with insulin or sulfonylureas: Increased hypoglycemia risk, may need dose reduction 7, 8
- May delay absorption of oral medications requiring rapid onset 8
Common Prescribing Pitfall
The most frequent error is attempting to order "Ozempic pills" - this formulation does not exist. If oral administration is required, prescribe oral semaglutide (Rybelsus) as a completely separate product with different dosing (3-14 mg daily) 2, 10.